Coronary Artery Disease, Diabetes
Conditions
Keywords
Coronary artery disease, Diabetes, Text messages
Brief summary
The study is a two-arm, parallel, randomized clinical trial. The purpose of the study is to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention, including lifestyles modification, medication adherence improvement and risk factors control among coronary heart disease (CHD) patients with diabetes. The participants will be randomized into intervention and control groups in a 1:1 ratio. The intervention group will receive 6 pre-designed text messages per week in addition to usual care for 6 months, while the control group will receive usual care.
Detailed description
Objective: This study aims to evaluate the effectiveness of automated mobile phone text message-based intervention for secondary prevention, including lifestyles modification, medication adherence improvement and risk factors control among CHD patients with diabetes. We hypothesized that an intervention using mobile phone text based education and reminder can improve risk factors control and medication adherence for CHD patients. Study design: The study is a two-arm, parallel, randomized clinical trial. Patients will be eligible if they have documented CHD defined as having history of myocardial infarction and percutaneous coronary intervention (PCI), have a history of diabetes mellitus, have the capability of reading and sending short message, and are able to provide informed consent. Patients will be excluded if they do not have an active mobile phone. The eligible participants will be allocated into intervention and control groups in a 1:1 ratio randomly. The intervention group will receive intervention of pre-designed text messages in addition to usual care, while the control group will receive usual care. All the participants will be followed up for 6 months. Study intervention: Participants in the intervention group will receive text messages for 6 months as well as usual care. They will receive one general messages, one hypertension message, one glucose control message, one lifestyle message, one medication adherence message and one physical activity message per week. Outcome measures: The primary endpoint is the change in glycemic hemoglobin (HbA1C) as measured by central blood sample. Secondary endpoints include a change in proportion of patients achieving HbA1C\<7%, body mass index (BMI), physical activity, medication adherence, systolic blood pressure, low-density lipoprotein cholesterol (LDL-C) and fasting blood glucose (FBG). Exploratory endpoints include long-term prognosis of the patients, such as death, nonfatal myocardial infarction, stroke and so on, as well as health status (SAQ and EQ-5D). Statistical analysis: Evaluation will be carried out on an intention-to-treat basis. Values of analyzed endpoints between intervention group and control group will be compared according to the analysis plan. We'll follow a prespecified analysis plan and subgroup analysis will be conducted accordingly.
Interventions
BEHAVIORALText messaging
Patients will receive regular semi-personalized text messages for 6 months. Each participants will receive 6 text messages per week, which will be sent at random times of the day (9.00am, 12noon, 4.00pm). They will receive one general messages, one hypertension message, one glucose control message, one lifestyle message, one medication adherence message and one physical activity message per week. Prior to study commencement, a bank of 270 messages have been developed based on guidelines and behavior change theory (BCT), and have underwent multidisciplinary expert review and qualitative review process.
Sponsors
China National Center for Cardiovascular Diseases
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Participants with coronary artery disease defined as history of myocardial infarction and PCI * History of diabetes * Capability to read and send text messages
Exclusion criteria
* Assumed poor adherence * Do not have an active mobile phone
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in glucose level measured by HbA1C level | Baseline; 6 months | We will measured the change in glucose level from baseline to 6 months. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in level of fasting blood glucose (FBG) | Baseline; 6 months | We will measure the change in FBG level from baseline to 6 months. |
| Change in body mass index (BMI) according to national standards | Baseline; 6 months | We will measured the change in BMI from baseline to 6 months. |
| Change in systolic blood pressure (SBP) obtained in office during each interview | Baseline; 6 months | We will measured the change in SBP from baseline to 6 months. |
| Change in proportion of patients achieving HbA1C<7% | Baseline; 6 months | We will measure the change in proportion of patients achieving HbA1C\<7% from baseline to 6 months. |
| Change in medication adherence | Baseline; 6 months | We will measure the change in medication adherence from baseline to 6 months. |
| Change in low-density lipoprotein cholesterol (LDL-C) level | Baseline; 6 months | We will measure the change in LDL-C level from baseline to 6 months. |
| Change in level of physical activity measured via International Physical Activity Questionnaire (IPAQ) scale | Baseline; 6 months | We will measure the change in IPAQ scale from baseline to 6 months. |
Countries
China
Outcome results
None listed